Expressive

rs10750840 - TPCN2

Magnitude 2.2 · 1 study on file

Reported associations

  • Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis - Unknown journal (n.d.) · Unknown authors · PubMed 32541925

    ABSTRACT: We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ethnic meta-analysis of 228,499 cases and 1,178,783 controls in the Million Veteran Program, DIAMANTE, Biobank Japan, and other studies. We report 568 associations, including 286 autosomal, 7 X chromosomal, and 25 identified in ancestry-specific analyses that were previously unreported. Transcriptome-wide association analysis detected 3,568 T2D-associations with genetically predicted gene expression in 687 novel genes; of these, 54 are known to interact with FDA-approved drugs. A polygenic risk score was strongly associated with increased risk of T2D-related retinopathy and modestly associated with chronic kidney disease (CKD), peripheral artery disease (PAD), and neuropathy. We investigated the genetic etiolo

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Diet

  • prioritize low glycemic index carbohydrates Moderate

    rs10750840 increases T2D risk; low glycemic load foods reduce blood glucose spikes and improve long-term glycemic control

    minimize refined grains, added sugars, and sugar-sweetened beverages

Discuss with your doctor

  • individualized Type 2 diabetes prevention plan Moderate

    rs10750840 increases Type 2 diabetes risk; physician-guided strategy optimizes risk reduction tailored to personal factors

Exercise

  • regular aerobic exercise Moderate

    rs10750840 associates with Type 2 diabetes risk; aerobic activity improves insulin sensitivity and glycemic control

    150 minutes per week moderate-intensity activity

Screening

  • periodic fasting glucose and HbA1c screening Moderate

    rs10750840 associates with Type 2 diabetes susceptibility; early detection enables preventive intervention before disease onset

    baseline at age 30, then every 1-3 years depending on results